Neurological & Psychological Disorders

News on research and diagnostic developments in neuroscience.

The £550,000 award is part of a larger multi-partner grant to develop and implement a point-of-care test to avoid antibiotic-related hearing loss in newborns.

Metafora is developing a blood test to help with early diagnosis of De Vivo disease, a metabolic disorder associated with glucose transport deficiency.

The designation will help the company accelerate the process of bringing the opioid addiction risk test through regulatory review and clearance.

Pro-Lab will shepherd Medicortex's kit through the regulatory processes in Canada and the UK, as well as clinically validate it. It will have exclusive rights to sell the kit in the two nations.

While a randomized-controlled trial is underway, Genomind hopes data from a new case-control study will convince insurers its PGx test can reduce healthcare utilization costs.